Fabian Gerlinghaus, Cellares CEO
November 6, 2023 10:55 AM ESTUpdated November 8, 07:06 AM
Deals
Manufacturing

Up­dat­ed: Cel­lares to pro­duce Ca­balet­ta’s au­toim­mune CAR-T can­di­date 

Anna Brown

News Reporter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

A new dawn for psy­che­delics? Com­pass could be the first to find out

Weeks af­ter TIG­IT fail, iTeos de­cides to wind down

Up­dat­ed: MD An­der­son-al­lied in­vest­ment firm tar­gets $250M for sec­ond can­cer biotech fund

Strand Ther­a­peu­tics re­ports promis­ing start for mR­NA can­cer ther­a­py

GSK, Spero re­port Phase 3 win for UTI an­tibi­ot­ic; Sper­o's stock soars

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times